Refine
Year of publication
Document Type
- Preprint (1838) (remove)
Has Fulltext
- yes (1838)
Is part of the Bibliography
- no (1838) (remove)
Keywords
- Kollisionen schwerer Ionen (33)
- heavy ion collisions (27)
- Deutsch (23)
- Quark-Gluon-Plasma (14)
- equation of state (13)
- QGP (12)
- Kongress (10)
- Syntax (10)
- quark-gluon plasma (10)
- Multicomponent Tree Adjoining Grammar (9)
Institute
- Physik (1136)
- Frankfurt Institute for Advanced Studies (FIAS) (806)
- Informatik (732)
- Medizin (164)
- Extern (82)
- Ernst Strüngmann Institut (66)
- Biowissenschaften (59)
- MPI für Hirnforschung (44)
- Mathematik (42)
- Psychologie (42)
Substantia nigra dopamine (SN DA) neurons are progressively lost in Parkinson disease (PD). While the molecular and cellular mechanisms of their differential vulnerability and degeneration have been extensively studied, we still know very little about potential functional adaptations of those SN DA neurons that – at least for some time – manage to survive during earlier stages of PD. We utilized a partial lesion 6-OHDA mouse model to characterize initial electrophysiological impairments and chronic adaptations of surviving identified SN DA neurons, both in vivo and in vitro. Early after lesion (3 weeks), we detected a selective loss of in vivo burst firing in surviving SN DA neurons, which was accompanied by in vitro pacemaker instability. In contrast, late after lesion (>2 months), in vivo firing properties of surviving SN DA neurons had recovered in the presence of 2-fold accelerated pacemaking in vitro. Finally, we show that this chronic cell-autonomous adaptation in surviving SN DA neurons was mediated by Kv4.3 channel downregulation. Our study demonstrates substantial homeostatic plasticity of surviving SN DA neurons after a single-hit non-progressive lesion, which might contribute to the phenotype of initially surviving SN DA neurons in PD.
The recently published experimental dependence of the J/psi suppression pattern in Pb+Pb collisions at the CERN SPS on the energy of zero degree calorimeter EZDC are analyzed. It is found that the data obtained within the minimum bias analysis (using theoretical Drell-Yan ) are at variance with the previously published experimental dependence of the same quantity on the transversal energy of neutral hadrons ET . The discrepancy is related to the moderate centrality region: 100 << Np << 200 (Np is the number of nucleon participants). This could result from systematic experimental errors in the minimum bias sample. A possible source of the errors may be contamination of the minimum bias sample by o -target interactions. The data obtained within the standard analysis (using measured Drell-Yan multiplicity) are found to be much less sensitive to the contamination.
The study of hidden charm production is an important part of the heavy ion program. The standard approach to this problem [1] assumes that c¯c bound states are created only at the initial stage of the reaction and then partially destroyed at later stages due to interactions with the medium [2, 3, 4].
The quantum mechanical formula for Mayer s second cluster integral for the gas of relativistic particles with hard-core interaction is derived. The proper pion volume calculated with quantum mechanical formula is found to be an order of magnitude larger than its classical evaluation. The second cluster integral for the pion gas is calculated in quantum mechanical approach with account for both attractive and hard-core repulsive interactions. It is shown that, in the second cluster approximation, the repulsive -interactions as well as the finite width of resonances give important but almost canceling contributions. In contrast, an appreciable deviation from the ideal gas of pions and pion resonances is observed beyond the second clus- ter approximation in the framework of the Van der Waals excluded-volume model.
The equation of state for the pion gas is analyzed within the third virial approximation. The second virial coeffcient is found from the pi pi -scattering data, while the third one is considered as a free parameter. The proposed model leads to a first-order phase transition from the pion gas to a more dense phase at the temperature Tpt < 136 MeV. Due to relatively low temperature this phase transition cannot be related to the deconfinement. This suggests that a new phase of hadron matter hot pion liquid may exist.
The high E(T) drop of J / psi to Drell-Yan ratio from the statistical c anti-c coalescence model
(2002)
The dependence of the J/psi yield on the transverse energy ET in heavy ion collisions is considered within the statistical c¯c coalescence model. The model fits the NA50 data for Pb+Pb collisions at the CERN SPS even in the high-ET region (ET >< 100 GeV). Here ET -fluctuations and ET -losses in the dimuon event sample naturally create the celebrated drop in the J/psi to Drell-Yan ratio.
Statistical coalescence model analysis of J / psi production in Pb + Pb collisions at 158 A GeV
(2001)
Production of J/psi mesons in heavy ion collisions is considered within the statistical coalescence model. The model is in agreement with the experi- mental data of the NA50 Collaboration for Pb+Pb collisions at 158 A·GeV in a wide centrality range, including the so called anomalous suppression domain. The model description of the J/ psi data requires, however, strong enhancement of the open charm production in central Pb+Pb collisions. This model prediction may be checked in the future SPS runs.
The J/psi yield at midrapidity at the top RHIC (relativistic heavy ion collider) energy is calculated within the statistical coalescence model, which assumes charmonium formation at the late stage of the reaction from the charm quarks and antiquarks created earlier in hard parton collisions. The results are compared to the new PHENIX data and to predictions of the standard models, which assume formation of charmonia exclusively at the initial stage of the reaction and their subsequent suppression. Two versions of the suppression scenario are considered. One of them assumes gradual charmonium suppression by comovers, while the other one supposes that the suppression sets in abruptly due to quark-gluon plasma formation. Surprisingly, both versions give very similar results. In contrast, the statistical coalescence model predicts a few times larger J/psi yield in the most central collisions.
Background: The increasing number of cases and hospital admissions due to COVID-19 created an urgent need for rapid, reliable testing procedures for SARS-CoV-2 in Emergency Departments (ED) in order to effectively manage hospital resources, allocate beds and prevent nosocomial spread of infection. The ID NOW™ COVID-19 assay is a simple, user-friendly, rapid molecular test run on an instrument with a small footprint enabling point-of-care diagnostics.
Methods: In the first wave, outsourced RT-PCR testing regularly required 36-48 hours before results were available. This prospective study was conducted in the second wave (October 2020-April 2021) and evaluated the impact the implementation of the ID NOW™ COVID-19 test in the ED had on clinical care processes and patient pathways. 710 patients were recruited upon arrival at the ED which included those presenting clinical symptoms, asymptomatic individuals or persons fulfilling epidemiological criteria. The first anterior nasal swab was taken by trained nurses in the ambulance or a separate consultation room. The ID NOW™ COVID-19 test was performed in the ED in strict compliance with the manufacturer’s instructions and positive or suspected cases were additionally tested with RT_PCR (cobas SARS-COV-2 RT-PCR, Roche) following collection of a second nasopharyngeal NP specimen.
Results: Swabs directly tested with the ID NOW™ COVID-19 test showed a diagnostic concordance of 98 % (sensitivity 99.59 %, specificity 94.55 %, PPV 97.6 %, NPV 99.05 %) compared to RT-PCR as reference. The 488 patients that tested positive with the ID NOW™ COVID-19 had a Ct range in RT-PCR results between 7.94 to 37.42 (in 23.2 % > 30). Two false negative results (0.28%) were recorded from patients with Ct values > 30. 14 (1.69%) discordant results were reviewed case-by-case and usually associated with either very early or very advanced stages of infection. Furthermore, patients initially negative with the ID NOW™ COVID-19 test and admitted to the hospital were tested again on days 5 and 12: no patient became positive.
Discussion: The ID NOW™ COVID-19 test for detection of SARS-CoV-2 demonstrated excellent diagnostic agreement with RT-PCR under the above-mentioned patients pathways implemented during the second wave. The main advantage of the system was the provision of reliable results within a few minutes. This not only allowed immediate initiative of appropriate therapy and care for COVID-19 (patient benefit) but provided essential information on isolation and thus available beds. This drastically helped the overall finances of the department and additionally allowed more patients to be admitted including those requiring immediate attention; this was not possible during the first wave since beds were blocked waiting for diagnostic confirmation. Our findings also show that when interpreting the results, the clinical condition and epidemiological history of the patient must be taken into account, as with any test procedure. Overall, the ID NOW™ COVID-19 test for SARS-CoV-2 provided a rapid and reliable alternative to laboratory-based RT-PCR in the real clinical setting which became an acceptable part of the daily routine within the ED and demonstrated that early patient management can mitigate the impact of the pandemic on the hospital.
Bipolar disorder (BD) is a heritable mental illness with complex etiology. While the largest published genome-wide association study identified 64 BD risk loci, the causal SNPs and genes within these loci remain unknown. We applied a suite of statistical and functional fine-mapping methods to these loci, and prioritized 22 likely causal SNPs for BD. We mapped these SNPs to genes, and investigated their likely functional consequences by integrating variant annotations, brain cell-type epigenomic annotations, brain quantitative trait loci, and results from rare variant exome sequencing in BD. Convergent lines of evidence supported the roles of SCN2A, TRANK1, DCLK3, INSYN2B, SYNE1, THSD7A, CACNA1B, TUBBP5, PLCB3, PRDX5, KCNK4, AP001453.3, TRPT1, FKBP2, DNAJC4, RASGRP1, FURIN, FES, YWHAE, DPH1, GSDMB, MED24, THRA, EEF1A2, and KCNQ2 in BD. These represent promising candidates for functional experiments to understand biological mechanisms and therapeutic potential. Additionally, we demonstrated that fine-mapping effect sizes can improve performance and transferability of BD polygenic risk scores across ancestrally diverse populations, and present a high-throughput fine-mapping pipeline (https://github.com/mkoromina/SAFFARI).